Sanofi and Regeneron To Present Alirocumab Clinical Data at the American ... - SYS-CON Media (press release)
Sanofi and Regeneron To Present Alirocumab Clinical Data at the American ... SYS-CON Media (press release)
Effects of Alirocumab, a Fully Human Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9, on Lipoprotein Particle Concentrations Determined by Nuclear Magnetic Resonance: Sub-Study of a Randomized Double-Blind Phase II Clinical ...
Sanofi and Regeneron To Present Alirocumab Clinical Data at the American ... - SYS-CON Media (press release) More...
Did you find this post helpful? |
Similar Threads
Thread
Thread Starter
Forum
Replies
Last Post
LipoScience's Vantera® Clinical Analyzer To Provide Hospitals And Physicians ... - PR Newswire (press release)
<img alt="" height="1" width="1" />
LipoScience's Vantera® Clinical Analyzer To Provide Hospitals And Physicians ...
PR Newswire (press release)
RALEIGH, N.C., May 22, 2013 /PRNewswire/ -- LipoScience, Inc., (NASDAQ: LPDX) a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care, today announced ...
and more »
LipoScience's Vantera® Clinical Analyzer To Provide Hospitals And Physicians ... - PR Newswire (press release)
More...
nmrlearner
Online News
0
05-22-2013 04:43 PM
LipoScience to Present at UBS Global Healthcare Services Conference - GlobeNewswire (press release)
<img alt="" height="1" width="1" />
LipoScience to Present at UBS Global Healthcare Services Conference
GlobeNewswire (press release)
LipoScience, Inc. is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile® test, measures the number of low density lipoprotein particles ...
and more »
LipoScience to Present at UBS Global Healthcare Services Conference - GlobeNewswire (press release)
More...
nmrlearner
Online News
0
05-14-2013 01:14 PM
LipoScience to Present at Barclays Global Healthcare Conference - NASDAQ (press release)
<img alt="" height="1" width="1" />
LipoScience to Present at Barclays Global Healthcare Conference
NASDAQ (press release)
LipoScience, Inc. is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile® test, measures the number of low density lipoprotein particles ...
LipoScience to Present at Barclays Global Healthcare Conference - NASDAQ (press release)
More...
nmrlearner
Online News
0
03-09-2013 11:56 PM
LipoScience to Present at Barclays Global Healthcare Conference - GlobeNewswire (press release)
<img alt="" height="1" width="1" />
LipoScience to Present at Barclays Global Healthcare Conference
GlobeNewswire (press release)
LipoScience, Inc. is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile® test, measures the number of low density lipoprotein particles ...
and more »
LipoScience to Present at Barclays Global Healthcare Conference - GlobeNewswire (press release)
More...
nmrlearner
Online News
0
03-07-2013 06:54 PM
Clinical Study Reveals Critical Importance of Measuring LDL-Particles for ... - MarketWatch (press release)
<img alt="" height="1" width="1" />
Clinical Study Reveals Critical Importance of Measuring LDL-Particles for ...
MarketWatch (press release)
LipoScience, Inc. is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile(R) test, measures the number of low density lipoprotein particles ...
Clinical Study Reveals Critical Importance of Measuring LDL-Particles for ... - MarketWatch (press release)
More...
nmrlearner
Online News
0
09-17-2012 02:13 PM
Clinical Data Suggests That Type 2 Diabetics with Low Cholesterol May Have ... - Business Wire (press release)
http://nt2.ggpht.com/news/tbn/SmKs3RuZYtGfdM/6.jpg
USA Today
<img alt="" height="1" width="1" />
Clinical Data Suggests That Type 2 Diabetics with Low Cholesterol May Have ...
Business Wire (press release)
1 LDL particle levels were measured using LipoScience's NMR LipoProfile test, a laboratory test that utilizes nuclear magnetic resonance spectroscopy to measure LDL and other lipoprotein particles. LDL particle information can help clinicians ...
Clinical Data Suggests That Type 2 Diabetics with Low Cholesterol May Have ...MarketWatch (press release)
all 313 news articles »
nmrlearner
Online News
0
11-15-2011 11:36 PM
Data Suggests LDL Particles May Be More Strongly Associated with ... - Business Wire (press release)
<img alt="" height="1" width="1" />
Data Suggests LDL Particles May Be More Strongly Associated with ...
Business Wire (press release)
LDL particle levels in both studies were measured using LipoScience's NMR LipoProfile ® test, a laboratory test that utilizes nuclear magnetic resonance (NMR) spectroscopy to measure LDL and other lipoprotein particles. LDL particle information can ...
and more »
Data Suggests LDL Particles May Be More Strongly Associated with ... - Business Wire (press release)
More...
nmrlearner
Online News
0
04-05-2011 10:53 PM
Clinical Study Demonstrates LDL Particles Are More Strongly Associated with ... - Business Wire (press release)
<img alt="" height="1" width="1" />
Clinical Study Demonstrates LDL Particles Are More Strongly Associated with ...
Business Wire (press release)
LDL particle levels were measured using LipoScience's NMR LipoProfile ® test, a laboratory test that utilizes nuclear magnetic resonance (NMR) spectroscopy to measure LDL and other lipoprotein particles. LDL particle information can help clinicians ...
Clinical Study Demonstrates LDL Particles Are More Strongly Associated with ...SunHerald.com
all 7 news articles »
Clinical Study Demonstrates LDL Particles Are More Strongly...